Meisner Derek M insider trades
Meisner Derek M has filed 19 Form 4s with the SEC that we hold, for Acumen Pharmaceuticals, Inc. (ABOS) (Chief Legal Officer & Corp Sec) and X4 Pharmaceuticals, Inc (XFOR) (Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 24 sales worth $348.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 16 sales ($248.8K). The largest single trade was a sale of 30,092 shares of Acumen Pharmaceuticals, Inc. worth $54.8K, dated 2026-01-08. The first filing on our record is dated 2021-08-19 and the latest 2026-03-10.
Acumen Pharmaceuticals, Inc. (ABOS)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-01-19 | S, sale reported on Form 4 | 8,933 | $31.1K | 2024-01-19 | SEC |
| 2025-01-03 | S, sale reported on Form 4 | 11,122 | $20.5K | 2025-01-07 | SEC |
| 2025-01-21 | S, sale reported on Form 4 | 3,418 | $5.4K | 2025-01-23 | SEC |
| 2026-01-05 | S, sale reported on Form 4 | 4,000 | $7.8K | 2026-01-07 | SEC |
| 2026-01-06 | S, sale reported on Form 4 | 7,097 | $14.0K | 2026-01-07 | SEC |
| 2026-01-06 | S, sale reported on Form 4 | 3,801 | $7.5K | 2026-01-07 | SEC |
| 2026-01-07 | S, sale reported on Form 4 | 10,070 | $20.0K | 2026-01-07 | SEC |
| 2026-01-07 | S, sale reported on Form 4 | 1,700 | $3.4K | 2026-01-07 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 30,092 | $54.8K | 2026-01-12 | SEC |
| 2026-01-08 | S, sale reported on Form 4 | 6,819 | $12.4K | 2026-01-12 | SEC |
| 2026-01-09 | S, sale reported on Form 4 | 5,200 | $9.2K | 2026-01-12 | SEC |
| 2026-01-12 | S, sale reported on Form 4 | 8,548 | $14.6K | 2026-01-12 | SEC |
| 2026-01-21 | S, sale reported on Form 4 | 2,247 | $4.1K | 2026-01-23 | SEC |
| 2026-01-22 | S, sale reported on Form 4 | 1,054 | $1.9K | 2026-01-23 | SEC |
| 2026-01-23 | S, sale reported on Form 4 | 5,633 | $10.7K | 2026-01-23 | SEC |
| 2026-01-26 | S, sale reported on Form 4 | 15,085 | $45.3K | 2026-01-28 | SEC |
| 2026-01-28 | S, sale reported on Form 4 | 2,671 | $8.0K | 2026-01-28 | SEC |
| 2026-02-27 | S, sale reported on Form 4 | 9,406 | $28.3K | 2026-03-03 | SEC |
| 2026-03-06 | S, sale reported on Form 4 | 2,090 | $6.8K | 2026-03-10 | SEC |
X4 Pharmaceuticals, Inc (XFOR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-17 | S, sale reported on Form 4 | 8,332 | $42.5K | 2021-08-19 | SEC |
| 2022-02-11 | S, sale reported on Form 4 | 15,909 | - | 2022-02-14 | SEC |
| 2022-06-16 | S, sale reported on Form 4 | 4,166 | - | 2022-06-17 | SEC |
| 2022-06-24 | S, sale reported on Form 4 | 4,166 | - | 2022-06-27 | SEC |
| 2022-08-17 | S, sale reported on Form 4 | 8,334 | - | 2022-08-19 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1752461) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
